BCL2 and diffuse large B-cell lymphoma: Moreover, a recent study in diffuse large B cell lymphoma (DLBCL) showed that active super-enhancers (SEs) harboring hypermutation are linked to the upregulation of oncogenes related to B cell developmental and malignant transformation, including BCL6, BCL2, and CXCR4 [15].